Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats

Journal of Autoimmunity

Volumn 11, Issue 4, 1998, Pages 329-334

  Chelmicka Schorr, Ewa ^a   Wiegmann, Katherine ^a   Wollmann, Robert ^a   Arnason, Barry G W ^a   Kim, Duk Hwan ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Encephalomyelitis; Experimental; FK 506

Indexed keywords

TACROLIMUS;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; DRUG EFFECT; FEMALE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031783953     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0205     Document Type: Article

References (22)

1. Polman C.H., Matthaei I., de Groot C.J.A., Koetsier J.C., Sminia T., Dijkstra C.D. 1988. Low-dose cyclosporin-A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 17: 209-216
2. 2-dihydro-cyclosporin in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Immunol. 63: 219-223
3. Mustafa M.I., Diener P., Sun J-B., Link H., Olsson T. 1993. Immunopharmacologic modulation of experimental allergic encephalomyelitis: low-dose cyclosporin-A treatment causes disease relapse and increased systemic T and B cell-mediated myelin-directed autoimmunity. Scand. J. Immunol. 38: 499-507
4. Paterson P.Y., Hanson M.A. 1969. Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats. J. Immunol. 103: 1311-1316
5. Minagawa H., Takenaka A., Itoyama Y., Mori R. 1987. Experimental allergic encephalomyelitis in the Lewis rat: a model of predictable relapse by Cyclophosphamide. J. Neuro. Sci. 78: 225-235
6. Lando Z., Teitelbaum D., Arnon R. 1979. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J. Immunol. 123: 2156-2160
7. The U.S. Multicenter FK 506 Liver Study Group. 1994. A comparison of tacrolimus (FK 506) and cyclosporin for immunosuppression in liver transplantation. N. Engl. J. Med. 331: 1110-1115
8. Sigal N.H., Lin C.S., Siekierka J.J. 1991. Inhibition of human T cell activation by FK-506, Rapamycin, and cyclosporin-A. Transplant. Proc. 23: 1-5
9. Wiederrecht G., Lam E., Hung S., Martin M., Sigal N. 1993. The mechanism of action of FK-506 and cyclosporin-A. Ann. NY Acad. Sci. 696: 9-19
10. Jiang H., Suguo H., Takahara S., Takano Y., Li D., Kameoka H., Moutabarrik A., Kokado Y., Ishibashi M., Okuyama A., Sonoda T. 1991. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro. Transplant. Proc. 23: 2933-2936
11. Noronha A., Arnason B.G.W. 1992. Multiple Schlerosis. In Textbook of Clin. Neuropharm. and Thera., 2nd edn. H.L. Klawanski, ed. Raven Press: New York, pp 287-296
12. Genestier L., Dearden-Badet M.T., Bonnefoy-Berard N., Lizard G., Revillard J.P. 1994. Cyclosporin-A and FK-506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. Cellular Immunol. 155: 283-291
13. Fruman D.A., Mather P.E., Burakoff S.J., Bierer B.E. 1992. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Immunol. 22: 2513-2517
14. Sekigawa T., Koshino K., Hishikawa T., Kaneko H., Takasaki Y., Hashimoto H., Hirose S., Inagaki Y., Yamamoto N. 1995. Inhibitory effect of the immunosuppressant FK 506 on apoptotic cell death induced by HIV-1 gp120. J. Clin. Immunol. 15: 312-317
15. Thomson A.W., Bonham C.A. 1995. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK 506). Its relevance to therapy of HIV infection. Adv. Exp. Med. Biol. 374: 211-216
16. + encephalitogenic T cells. Eur. J. Immunol. 24: 2609-2617
17. Adachi A., Araga S., Takahashi K. 1992. Immunosuppressive effect of FK 506 on experimental allergic neuritis in Lewis rats: change of T cell subsets. Intern. Med. 31: 6-10
18. Bolton C. 1991. The ability of myelin basic protein-sensitized leukocytes to adoptively transfer experimental allergic encephalomyelitis following coculture with FK 506, cyclosporine, or prednisolone. Transplantation Proc. 23: 3363-3364
19. Inamura N., Hashimoto M., Nakahara K., Nakajima Y., Nishio M., Aoki H., Yamaguchi I., Kohsaka M. 1988. Immunosuppressive effect of FK 506 on experimental allergic encephalomyelitis in rats. Int. J. Immunopharmac. 10: 991-995
20. Deguchi K., Takeuchi H., Miki H., Yamada A., Touge T., Terada S., Nishioka M. 1991. Effects of FK 506 on acute experimental allergic encephalomyelitis. Transplant. Proc 23: 3360-3362
21. Lemster B., Huang L.L., Irish W., Woo J., Carroll P.B., Abu-Elmagd K., Rilo H.R., Johnson N., Russell-Hall R., Fung J.J. 1994. Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD55RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity 19: 89-98
22. Wilson J.R., Conwit R.A., Eidelman B.H., Starzl T., Abu-Elmagd K. 1994. Sensorimotor neuropathy resembling CIDP in patients receiving FK 506. Muscle & Nerve 17: 528-532